Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration
- 4 November 2016
- journal article
- other
- Published by Springer Nature in Acta Neuropathologica
- Vol. 132 (6) , 935-937
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (AG043503, AG017586, AG10124)
- Dana Foundation
- Avid Radiopharmaceuticals
This publication has 9 references indexed in Scilit:
- Multimodal imaging evidence of pathology-mediated disease distribution in corticobasal syndromeNeurology, 2016
- [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degenerationActa Neuropathologica, 2016
- In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging BrainThe Journal of Neuroscience, 2016
- 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology inMAPTmutation carriersBrain, 2016
- An autoradiographic evaluation of AV-1451 Tau PET in dementiaActa Neuropathologica Communications, 2016
- Characterization of tau positron emission tomography tracer [18F]AV‐1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementiasAlzheimer's & Dementia, 2016
- Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissueAnnals of Neurology, 2015
- Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal agingAlzheimer's & Dementia, 2013
- Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)Journal of Molecular Neuroscience, 2011